Katie Doores

Has grant

Senior Lecturer/MRC Career Development Fellow

King’s College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Katie Doores is a Senior Lecturer and MRC Career Development Fellow at King's College London, UK. Her research focuses on the structural dynamics and immunological responses related to viral infections, particularly SARS-CoV-2 and New World mammarenaviruses. Recent publications include studies on antibody responses post vaccination and infections, as well as the evolution of the viral spike glycoprotein.

Recent Grants

Grant: Close

Immunological responses to emerging phlebo- and arena-viruses

Open Date: 2015-12-01

Close Date: 2018-11-01

Grant: Close

Dissecting host immune responses to bacteria and HIV carbohydrate antigens to guide vaccine design

Open Date: 2013-06-01

Close Date: 2018-10-01

Grant: Close

Broadly neutralizing antibody responses in HIV infection to guide vaccine design.

Open Date:

Close Date:

Articles (16)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (23)

Mohammad Ibrahim

King’s College London

UNITED KINGDOM

Katie Doores

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (16)

Spike-specific IgG4 generated post BNT162b2 mRNA vaccination is inhibitory when directly competing with functional IgG subclasses

Structure and stabilization of the antigenic glycoprotein building blocks of the New World mammarenavirus spike complex

Profiling serum immunodominance following SARS-CoV-2 primary and breakthrough infection reveals distinct variant-specific epitope usage and immune imprinting

Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein

Endogenous antibody responses in REGN-COV2-treated SARS-CoV-2-infected individuals

Contrasting Modes of New World Arenavirus Neutralization by Immunization-Elicited Monoclonal Antibodies

SARS-CoV-2–specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies

The legacy of maternal SARS-CoV-2 infection on the immunology of the neonate

TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.

Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England.

Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings.

Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.

A dynamic COVID-19 immune signature includes associations with poor prognosis.

Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome.

Targeting Glycans on Human Pathogens for Vaccine Design.

Collaborators (23)

Mohammad Ibrahim

Dietmar Hammerschmid

Irene del Molino del Barrio

Donald Benton

Weng Ming Ng

Jerry Tam

Thomas A. Bowden

Valeria Calvaresi

Eamonn Reading

Caroline Goujon

Richard Bradshaw

Abhishek Das

Rachel Tribe

Yin Wu

Stuart Neil

Daniel Pinschewer

Pärt Peterson

Felicity Aiano

Miguel Muñoz-Ruiz

Hataf khan

Deena Gibbons

Argyris Politis

Suzanne Pickering

Make your next move.